Advertisement
Screener

HEPION PHARMACEUTICALS, INC. (HEPA) Additional Paid in Capital, Common Stock

1.6 / 5 stars · 19/59 Roast Me

HEPION PHARMACEUTICALS, INC. Additional Paid in Capital, Common Stock

HEPION PHARMACEUTICALS, INC. (HEPA) had Additional Paid in Capital, Common Stock of $247.06 million as of 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital

us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2025-08-14

  • 2025-06-30: Additional Paid in Capital, Common Stock $247.06M.
  • 2025-03-31: Additional Paid in Capital, Common Stock $246.12M.
  • 2024-12-31: Additional Paid in Capital, Common Stock $234.25M.
  • 2024-09-30: Additional Paid in Capital, Common Stock $234.22M.
Period endAdditional Paid in Capital, Common StockAdditional Paid in Capital, Common Stock as first filed
2025-06-30$247.06M
10-Q · filed 2025-08-14
2025-03-31$246.12M
10-Q · filed 2025-05-19
2024-12-31$234.25M
10-Q · filed 2025-08-14
2024-09-30$234.22M
10-Q · filed 2024-11-14
2024-06-30$233.33M
10-Q · filed 2024-08-13
2024-03-31$233.30M
10-Q · filed 2024-05-21
2023-12-31$230.29M
10-Q · filed 2024-11-14
2023-09-30$228.12M
10-Q · filed 2023-11-20
2023-06-30$227.81M
10-Q · filed 2023-08-14
2023-03-31$224.49M
10-Q · filed 2023-05-12
2022-12-31$223.95M
10-K · filed 2024-04-16
$223.94M
10-K · filed 2023-04-10
2022-09-30$226.54M
10-Q · filed 2022-11-14
2022-06-30$225.99M
10-Q · filed 2022-08-15
2022-03-31$225.35M
10-Q · filed 2022-05-16
2021-12-31$224.79M
10-K · filed 2023-04-10
2021-09-30$228.02M
10-Q · filed 2021-11-15
2021-06-30$226.83M
10-Q · filed 2021-08-16
2021-03-31$226.02M
10-Q · filed 2021-05-14
2020-12-31$142.91M
10-K · filed 2022-04-08
2020-09-30$110.31M
10-Q · filed 2020-11-16
2020-06-30$108.92M
10-Q · filed 2020-08-12
2020-03-31$104.46M
10-Q · filed 2020-06-29
2019-12-31$97.65M
10-K · filed 2021-03-31
2019-09-30$95.80M
10-Q · filed 2019-11-14
2019-06-30$95.77M
10-Q · filed 2019-08-14
2019-03-31$77.33M
10-Q · filed 2019-05-15
2018-12-31$76.65M
10-K · filed 2020-05-14
$76.65M
10-K · filed 2019-03-14
2018-09-30$77.46M
10-Q · filed 2018-11-14
2018-06-30$72.13M
10-Q · filed 2018-08-14
2018-03-31$71.71M
10-Q · filed 2018-05-15
2017-12-31$69.68M
10-K · filed 2019-03-14
$69.67M
10-KT · filed 2018-03-26
2017-09-30$69.22M
10-Q · filed 2017-11-14
2017-06-30$67.51M
10-KT · filed 2018-03-26
2017-03-31$60.12M
10-Q · filed 2017-04-12
2016-12-31$58.58M
10-Q · filed 2017-02-14
2016-09-30$44.60M
10-Q · filed 2016-11-14
2016-06-30$32.23M
10-KT · filed 2018-03-26
2016-03-31$27.00M
10-Q · filed 2016-05-13
2015-12-31$26.77M
10-Q · filed 2016-02-12
2015-09-30$17.39M
10-Q · filed 2015-11-12
2015-06-30$17.35M
10-K · filed 2016-09-28
2015-03-31$16.42M
10-Q · filed 2015-05-14
2014-12-31$12.74M
10-Q · filed 2015-02-12
2014-09-30$7.43M
10-Q · filed 2014-11-13
2014-06-30$2.49M
10-K · filed 2015-09-25
2014-03-31$2.46M
10-Q · filed 2014-05-15
2013-12-31-$48.00
10-Q · filed 2014-02-05
2013-09-30-$900.00
10-Q · filed 2013-11-19
2013-06-30-$900.00
10-K · filed 2014-09-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87